Jiangsu Hanbon Science and Technology Co., Ltd.

¥23.81As of Sun 8 Nov 2026, 12:00 UTC
SSE:688755Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR —
Div yield 0.78%
ROE 6.96%
Medical Devices
Beta (5Y) —
PE TTM 31.45
TSR TTM (30.55%)
Mkt cap ¥2.724B
ROIC 19.16%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥26
7.43%
(76.27%)
Hold 9|5|1|11|8
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.39
0.43
0.46
0.47
27.08%
24.58%
26.02%
25.19%
Revenue¥M
163.2
170.5
169.3
171.6
(0.96%)
4.42%
6.39%
9.85%
Peers (US$408.3M)
Cap (US$)
PE
417.1M
102.1x
411.9M
273.1x
406.0M
26.82x
407.9M
—
Capital
TTM
5Y
10Y
Leveragex
0.718
0.393
0.331
EBIT/Intx
2.069
1.386
1.449
Own earn%
(255.68)
(144.98)
(131.65)
Sh yield%
42.02
55.06
49.25
Owners
Insiders/Inst%
12.98
62.29
Short interest%
4.10
SBC / revenue%
5.96
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
8–16
$1 testx
—
Incr. ROIC%
3